These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7867438)

  • 21. Transintestinal elimination of ciprofloxacin.
    Rohwedder R; Bergan T; Thorsteinsson SB; Scholl H
    Chemotherapy; 1990; 36(2):77-84. PubMed ID: 2311444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):515-20. PubMed ID: 2504591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.
    Bressolle F; Brès J; Mourad G
    Clin Pharmacokinet; 1989 Nov; 17(5):367-73. PubMed ID: 2582694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function.
    Webb DB; Roberts DE; Williams JD; Asscher AW
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():83-7. PubMed ID: 3804907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biapenem pharmacokinetics in healthy volunteers and in patients with impaired renal function.
    Koeppe P; Höffler D; Fitzen B
    Arzneimittelforschung; 1997 Nov; 47(11):1250-6. PubMed ID: 9428983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of renal failure on ciprofloxacin pharmacokinetics in rats.
    Nouaille-Degorce B; Veau C; Dautrey S; Tod M; Laouari D; Carbon C; Farinotti R
    Antimicrob Agents Chemother; 1998 Feb; 42(2):289-92. PubMed ID: 9527774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between renal function and disposition of oral ciprofloxacin.
    Forrest A; Weir M; Plaisance KI; Drusano GL; Leslie J; Standiford HC
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1537-40. PubMed ID: 3190182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.
    Singlas E; Taburet AM; Landru I; Albin H; Ryckelinck JP
    Eur J Clin Pharmacol; 1987; 31(5):589-93. PubMed ID: 3830244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():73-9. PubMed ID: 3182465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
    Lameire N; Malerczyk V; Drees B; Lehr K; Rosenkranz B
    Clin Pharmacol Ther; 1992 Jul; 52(1):24-30. PubMed ID: 1623690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of ciprofloxacin following intravenous administration in dogs.
    Abadía AR; Aramayona JJ; Muñoz MJ; Pla Delfina JM; Saez MP; Bregante MA
    J Vet Pharmacol Ther; 1994 Oct; 17(5):384-8. PubMed ID: 7853464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleural penetration of ciprofloxacin in patients with empyema thoracis.
    Morgenroth A; Pfeuffer HP; Seelmann R; Schweisfurth H
    Chest; 1991 Aug; 100(2):406-9. PubMed ID: 1864115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transintestinal elimination of ciprofloxacin.
    Rohwedder RW; Bergan T; Thorsteinsson SB; Scholl H
    Diagn Microbiol Infect Dis; 1990; 13(2):127-33. PubMed ID: 2369809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis.
    Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann ChJ
    Acta Med Austriaca; 2002; 29(3):112-6. PubMed ID: 12168566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics of temocillin in patients with normal and impaired renal function.
    Boelaert J; Daneels R; Schurgers M; Lambert AM; Van Landuyt HW; Mellows G; Wolf J; Swaisland AJ
    J Antimicrob Chemother; 1983 Apr; 11(4):349-56. PubMed ID: 6853404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ceftezole in patients with normal and impaired renal function.
    Ohkawa M; Kuroda K
    Chemotherapy; 1980; 26(4):242-7. PubMed ID: 7389424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of ciprofloxacin in patients with impaired renal function.
    Boelaert J; Valcke Y; Schurgers M; Daneels R; Rosseneu M; Rosseel MT; Bogaert MG
    J Antimicrob Chemother; 1985 Jul; 16(1):87-93. PubMed ID: 2931415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of ciprofloxacin in young healthy volunteers].
    Liang D; Qin Y; Xu N; Zhang H; Li J
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):306-8. PubMed ID: 8288206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairment.
    Halstenson CE; Triscari J; DeVault A; Shapiro B; Keane W; Pan H
    J Clin Pharmacol; 1992 Feb; 32(2):124-32. PubMed ID: 1613121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin penetration in pancreatic juice.
    Pederzoli P; Falconi M; Bassi C; Vesentini S; Orcalli F; Scaglione F; Solbiati M; Messori A; Martini N
    Chemotherapy; 1987; 33(6):397-401. PubMed ID: 3428007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.